The 4 references without contexts in paper V. Dobronravov A., A. Smirnov V., I. Kayukov G., В. Добронравов А., А. Смирнов В., И. Каюков Г. (2009) “МНОГОГРАННАЯ АЛЬБУМИНУРИЯ: АСПЕКТЫ КЛИНИЧЕСКОГО ЗНАЧЕНИЯ // MANYSIDED ALBUMINURIA: ASPECTS OF CLINICAL VALUE” / spz:neicon:nefr:y:2009:i:3:p:33-38

31
Mann JF, Yi QL, Gerstein HC. Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease. Kidney Int 2004; 66 [suppl 92]:59-62
(check this in PDF content)
32
Wachtell K, IbseN H, Olsen MH et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE study. Ann Intern Med 2003 139: 901-906
(check this in PDF content)
33
Toto RD. Proteinuria and hypertensive nephrosclerosis in African-Americans. Kidney Int 66 [suppl 92]:102-104
(check this in PDF content)
34
Weir MR. M icroalbum inuria in type 2 diabetes: An im portant, overlooked cardiovascular risk factor. J Clin Hypertens 2004 6: 134-143 3 5 . Dinneen, SF, Gerstein, HC. The association of m icroalbum inuria and m ortality in non-insulin-dependent
(check this in PDF content)